[Does asparaginase therapy lead to consumption coagulopathy?].
D000328:Adult; D001215:Asparaginase / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008875:Middle Aged
D005165:Factor V; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D001215:Asparaginase
Führt die Asparaginasetherapie zu einer Verbrauchscoagulopathie?